Man Collapses During Trump’s Oval Office Announcement
During a Thursday press conference in the Oval Office, a man collapsed behind President Donald Trump while attending an event with drugmakers discussing coverage expansion and price reductions for obesity treatments Zepbound and Wegovy.
As the man fainted, officials quickly responded. Dr. Mehmet Oz, the Centers for Medicare and Medicaid Services Administrator, supported the man's head as he was gently lowered to the floor. The exact cause of the collapse was not immediately known.
“During the Most Favored Nations Oval Office Announcement, a representative with one of the companies fainted. The White House Medical Unit quickly jumped into action, and the gentleman is okay. The Press Conference will resume shortly.” — White House press secretary Karoline Leavitt
Leavitt confirmed the man was a guest of health care companies Eli Lilly and Novo Nordisk, who attended the event. Although the man did not return to the Oval Office, President Trump later stated that he was feeling lightheaded but was now fine.
About an hour after the incident, Trump resumed the weight-loss drug event and announced a deal with Eli Lilly and Novo Nordisk to increase Medicare coverage and lower prices for the popular obesity drugs Zepbound and Wegovy.
“The gentleman was feeling lightheaded but is OK now.” — President Donald Trump
Newsweek reached out to the White House for further comment via email.
Summary
A man fainted behind President Trump during a drug pricing announcement but recovered quickly; the event resumed with a significant deal to enhance Medicare coverage for obesity treatments.